上皮细胞早老素-1通过调控EGFR-COX2信号驱动结直肠肿瘤生长
该研究探讨早老素-1(PSEN1)在结直肠癌(CRC)中的作用。在人类CRC样本、AOM-DSS和Apc min/+小鼠模型及人CRC细胞异种移植模型中,PSEN1在肠上皮表达且在人类CRC中水平升高;Psen1缺失小鼠仅形成小肿瘤,Psen1缺失的人癌细胞系致瘤性降低,Psen1缺失的Apc min/+小鼠来源的肿瘤类器官生长受限、细胞增殖减少。机制上PSEN1通过增强EGFR信号和COX-2产生促进肿瘤细胞增殖,外源性PGE2通过EP4受体信号逆转PSEN1缺失肿瘤细胞的生长缓慢。结论认为Psen1通过NOTCH1加工增加EGFR信号并激活COX-2-PGE2通路驱动肿瘤发展,抑制PSEN1可能是治疗CRC的有用策略。
要点
- PSEN1在肠上皮表达,且在人类结直肠癌中水平升高。
- Psen1缺失小鼠仅形成小肿瘤,Psen1缺失人癌细胞系致瘤性降低。
- PSEN1通过NOTCH1加工增强EGFR信号并激活COX-2-PGE2通路驱动肿瘤发展。
核心结论
- Psen1通过NOTCH1加工增加EGFR信号并激活COX-2-PGE2通路驱动肿瘤发展,抑制PSEN1可能是治疗结直肠癌的有用策略。
研究设计与样本
- 研究检测了人类结直肠癌与对照样本中PSEN1及γ-分泌酶复合体蛋白。
- 使用新构建的上皮特异性Psen1缺陷小鼠在AOM-DSS和Apc min/+模型中分析肿瘤形成。
- 在异种移植肿瘤模型中研究Psen1缺陷的人结直肠癌细胞。
- 分析肿瘤来源类器官的生长并进行RNA-Seq以鉴定Psen1调控的通路。
- 构建Tumouroids研究EGFR激活并评估前列腺素类物质的影响。
主要发现
- PSEN1在肠上皮表达,其在人类结直肠癌中的水平升高。
- Psen1缺陷小鼠仅形成小肿瘤,Psen1缺陷的人癌细胞系致瘤性降低。
- 来自Psen1缺陷Apc min/+小鼠的Tumouroids表现出生长受限和细胞增殖减少。
- 在分子水平,PSEN1通过增强EGFR信号和COX-2产生促进肿瘤细胞增殖。
- 外源性给予PGE2通过PGE2受体4(EP4)受体信号逆转PSEN1缺陷肿瘤细胞的缓慢生长。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Psen1 was previously characterised as a crucial factor in the pathogenesis of neurodegeneration in patients with Alzheimer's disease. Little, if any, is known about its function in the gut. Here, we uncovered an unexpected functional role of Psen1 in gut epithelial cells during intestinal tumourigenesis. DESIGN: Human colorectal cancer (CRC) and control samples were investigated for PSEN1 and proteins of theγ-secretase complex. Tumour formation was analysed in the AOM-DSS and Apc min/+ mouse models using newly generated epithelial-specific Psen1 deficient mice. Psen1 deficient human CRC cells were studied in a xenograft tumour model. Tumour-derived organoids were analysed for growth and RNA-Seq was performed to identify Psen1-regulated pathways. Tumouroids were generated to study EGFR activation and evaluation of the influence of prostanoids. RESULTS: PSEN1 is expressed in the intestinal epithelium and its level is increased in human CRC. Psen1-deficient mice developed only small tumours and human cancer cell lines deficient in Psen1 had a reduced tumourigenicity. Tumouroids derived from Psen1-deficient Apc min/+ mice exhibited stunted growth and reduced cell proliferation. On a molecular level, PSEN1 potentiated tumour cell proliferation via enhanced EGFR signalling and COX-2 production. Exogenous administration of PGE2 reversed the slow growth of PSEN1 deficient tumour cells via PGE2 receptor 4 (EP4) receptor signalling. CONCLUSIONS: Psen1 drives tumour development by increasing EGFR signalling via NOTCH1 processing, and by activating the COX-2-PGE2 pathway. PSEN1 inhibition could be a useful strategy in treatment of CRC.
引用
- Gamez-Belmonte R, Mahapatro M, Erkert L, et al. Epithelial presenilin-1 drives colorectal tumour growth by controlling EGFR-COX2 signalling. Gut. 2022. PMID: 36261293. doi:10.1136/gutjnl-2022-327323
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。